Chemistry and insulin-like properties of vanadium(IV) and vanadium(V) compounds (Q33961272)

30 July 2017

1 reference

title

Chemistry and insulin-like properties of vanadium(IV) and vanadium(V) compounds (English)

1 reference

30 July 2017

1 reference

0 references

Crans DC

1 reference

30 July 2017

publication date

1 May 2000

1 reference

Journal of Inorganic Biochemistry

30 July 2017

published in

1 reference

30 July 2017

1 reference

30 July 2017

issue

1-2

1 reference

30 July 2017

page(s)

123-131

1 reference

Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Vanadium compounds as insulin mimics

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

In vivo antidiabetic actions of naglivan, an organic vanadyl compound in streptozotocin-induced diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Bis(maltolato)oxovanadium(IV) is a potent insulin mimic

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV)

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

A new orally active insulin-mimetic vanadyl complex: bis(pyrrolidine-N-carbodithioato)oxovanadium (IV).

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Evidence for the Distinct Vanadyl(+4)-Dependent Activating System for Manifesting Insulin-Like Effects†

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

L-Glutamic acid gamma-monohydroxamate. A potentiator of vanadium-evoked glucose metabolism in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Preparation and characterization of dipicolinatovanadium(V) complexes. Kinetics and mechanism of their reaction with hydrogen peroxide in acidic media

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Primary hypoadrenocorticism in ten cats

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Serum fructosamine concentration as an index of glycemia in cats with diabetes mellitus and stress hyperglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Vanadium(V)-protein model studies: solid-state and solution structure

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Six-co-ordinated vanadium-(IV) and -(V) complexes of benzimidazole and pyridyl containing ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Structural and kinetic characterization of simple complexes as models for vanadate-protein interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Enzyme Interactions with Labile Oxovanadates and Other Polyoxometalates

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Vanadium oxoanions and cAMP-dependent protein kinase: an anti-substrate inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Modulation of insulin action by vanadate: evidence of a role for phosphotyrosine phosphatase activity to alter cellular signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Multifunctional actions of vanadium compounds on insulin signaling pathways: evidence for preferential enhancement of metabolic versus mitogenic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Discovery of a Small Molecule Insulin Mimetic with Antidiabetic Activity in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Synthesis, Structure, and Biological Activity of a New Insulinomimetic Peroxovanadium Compound: Bisperoxovanadium Imidazole Monoanion

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

Crystal structure of bovine low molecular weight phosphotyrosyl phosphatase complexed with the transition state analog vanadate

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2800%2900048-9

7 January 2021

10.1016/S0162-0134(00)00048-9

Identifiers

DOI

1 reference

30 July 2017

1 reference